A Multicenter, Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses, 25 Mg Twice Daily and 100 Mg Twice Daily, of PG-760564 in Adult Patients With RA [rheumatoid arthritis] Receiving Methotrexate

Trial Profile

A Multicenter, Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses, 25 Mg Twice Daily and 100 Mg Twice Daily, of PG-760564 in Adult Patients With RA [rheumatoid arthritis] Receiving Methotrexate

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2011

At a glance

  • Drugs PG 760564 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Feb 2008 Status changed from recruiting to completed according to NCT.
    • 19 Nov 2007 The expected completion date for this trial is now 1 Jan 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top